MEN1 and gastrin-producing neuroendocrine tumor: Because of the excellent prognosis of MEN1/ZES patients with small gastrinomas (<1.5–2 cm), these more aggressive resections are not recommended routinely in most current guidelines [114,118,121,122,123,124,125].